[an error occurred while processing this directive] | [an error occurred while processing this directive]
Influence of microextension on clinical target volume delineation in adenocarcinoma and squamous cell carcinoma among patients with non-small cell lung cancer
Zhang Weike,Xie Limei,Wang Zhongshan,Pang Dequan
Department of Oncology,Laigang Hospital Affiliated to Taishan Medical College,Laiwu 271100,China
AbstractObjective To better understand the relationship between the maximum tumor diameter and the most distant micrometastases in different types of non-small cell lung cancer (NSCLC) and to provide histological evidence for the delineation of clinical target volume (CTV) from gross tumor volume.Methods We retrospectively studied the pathological specimens from 113 surgically treated NSCLC patients (44 squamous cell carcinoma patients and 69 adenocarcinoma patients) who were admitted to our hospital from 2014 to 2015. The maximum tumor diameter was determined by a combination of gross and microscopic measurements. Micrometastases were microscopically determined. The distances between the tumor edges and micrometastases outside the tumor boundaries were measured by an ocular micrometer followed by a calculation. Quantitative data were analyzed by t test, and qualitative data were analyzed by logistic regression. Results The regression relationship between the maximum tumor diameter and micrometastases was significant in the adenocarcinoma group, but not significant in the squamous cell carcinoma group (P=0.151). The association between the presence or absence of lymph node metastasis and the most distant micrometastasis was significant in the adenocarcinoma group, but not significant in the squamous cell carcinoma group (P=0.597). No association between the degree of tumor differentiation and the most distant micrometastasis was observed in either group (P=0.113). The average measurement of the most distant micrometastases was 2.94 mm in the adenocarcinoma group, with 7.5 mm as the distance to cover 95% of the most distant micrometastases. To reach the same coverage, 4 mm was needed for tumor size smaller than 3 cm, 6 mm for those between 3 cm and 5 cm, and 7.5 mm for those larger than 5 cm. The average measurement of the most distant micrometastases was 2.69 mm in the squamous cell carcinoma group, with 6 mm as the distance to cover 95% of the most distant micrometastases. Conclusions For NSCLC, the most distant micrometastasis of adenocarcinoma is associated with the maximum tumor diameter and presence or absence of lymph node metastasis, and the CTV should thus be adjusted accordingly;no relevance between the most distant micrometastasis and maximum tumor diameter is observed in squamous cell carcinoma;there is no relationship between the most distant micrometastasis and the degree of tumor differentiation in adenocarcinoma and squamous cell carcinoma.
Zhang Weike,Xie Limei,Wang Zhongshan et al. Influence of microextension on clinical target volume delineation in adenocarcinoma and squamous cell carcinoma among patients with non-small cell lung cancer[J]. Chinese Journal of Radiation Oncology, 2017, 26(5): 522-526.
Zhang Weike,Xie Limei,Wang Zhongshan et al. Influence of microextension on clinical target volume delineation in adenocarcinoma and squamous cell carcinoma among patients with non-small cell lung cancer[J]. Chinese Journal of Radiation Oncology, 2017, 26(5): 522-526.
[1] Lee NY,Terezakis SA.Intensity-modulated radiation therapy[J].J Surg Oncol,2008,97(8):691-696.DOI:10.1002/jso.21014. [2] Kong FM,Zhao J,Wang JB,et al. Radiation dose effect in locally advanced non-small cell lung cancer[J].J Thorac Dis,2014,6(4):336-347.DOI:10.3978/j.issn.2072-1439.2014.01.23. [3] Burnet NG,Thomas SJ,Burton KE,et al. Defining the tumour and target volumes for radiotherapy[J].Cancer Imag,2004,4(2):153-161.DOI:10.1102/1470-7330.2004.0054. [4] Travis WD,Brambilla E,Noguchi M,et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma[J].J Thorac Oncol,2011,6(2):244-285.DOI:10.1097/JTO.0b013e318206a221. [5] Aupérin A,Péchoux CL,Rolland E,et al. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer[J].J Clin Oncol,2010,28(13):2181-2190.DOI:10.1200/JCO.2009.26.2543. [6] Chang JY,Bradley JD,Govindan R,et al. Perez and brady’s principle and practice of radiation oncology[M].Philadelphia:Wolter Kluwer/Lippincott Williams& Wikins,2013:1076-1108. [7] Giraud P,Antoine M,Larrouy A,et al. Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning[J].Int J Radiat Oncol Bid Phys,2000,48(4):1015-1024. [8] Singh AK,Lockett MA,Bradley JD.Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy[J].Int J Radiat Oncol Biol Phys,2003,55(2):337-341. [9] Ruyck KD,Sabbe N,Oberije C,et al. Development of a multicomponent prediction model for acute esophagitis in lung cancer patients receiving chemoradiotherapy[J].Int J Radiat Oncol Biol Phys,2011,81(2):537-544.DOI:10.1016/j.ijrobp.2011.03.012. [10] Perez CA,Pajak TF,Rubin P,et al. Long-term observations of the patterns of failure in patients with unresectable non-oat cellcarcinoma of the lung treated with definitive radiotherapy report by the radiation therapy oncology group[J].Cancer,1987,59(11):1874-1881. [11] Martel MK,Ten Haken RK,Hazuka MB,et al. Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients[J].Lung Cancer,1999,24(1):31-37. [12] Abid SH,Malhotra V,Perry MC.Radiation-induced and chemotherapy-induced pulmonary injury[J].Curr Opin Oncol,2001,13(4):242-248. [13] Zhang YK,Li BS.Research progress on the correlative factors with acute radiation-pneumonitis and acute radiation-esophagitis in the treatment of three-dimensional conformal radiotherapy for advanced non-small cell lung cancer[J].Nat Med Front China,2010,5(9):14-18. [14] Sekine I,Sumi M,Ito Y,et alRetrospective analysis of steroid therapy for radiation-induced lung injury in lung cancer patients[J].Radiother Oncol,2006,80(1)93-97.DOI:10.1016/j.radonc.2006.06.007. [15] Avanzo M,Trovo M., Furlan C,et al. Normal tissue complication probability models for severe acute radiological lung injury after radiotherapy for lung cancer[J].Phys Med,2015,31(1):1-6.DOI:10.1016/j.ejmp.2014.10.006. [16] Agolli L,Valeriani M,Nicosia L,et al. Stereotactic ablative body radiotherapy (SABR) in pulmonary oligometastatic/oligorecurrent non-small cell lung cancer patients:a new therapeutic approach[J].Anticancer Res,2015,35(11):6239-6246. [17] Yorke ED,Jackson A,Rosenzweig KE,et al. Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study[J].Int J Radiat Oneol Biol Phys,2005,63(3):672-682.DOI:10.1016/j.ijrobp.2005.03.026. [18] Wang SL,Liao ZX,Wei X,et al. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT)[J].Int J Radiat Oncol Biol Phys,2006,66(5):1399-1407.DOI:10.1016/j.ijrobp.2006.07.1337. [19] Song CH,Pyo H,Moon SH,et al. Treatment-related pneumonitis and acute esophagitis in non-small-cell lung cancer patients treated with chemotherapy and helical tomotherapy[J].Int J Radiat Oncol Biol Phys,2010,78(3):651-658.DOI:10.1016/j.ijrobp.2009.08.068. [20] Fidler IJ,Radinsky R.Genetic control of cancer metastasis[J].J Natl Cancer Inst,1990,82(3):166-168. [21] Pritt B,Tessitore JJ,Weaver DW,et al. The effect of tissue fixation and processing on breast cancer size[J].Human Pathol,2005,36:756-760.DOI:10.1016/j.humpath.2005.04.018. [22] 李万龙,于金明,刘国华,等.NSCLC影像学与病理学靶区关系的研究[J].中华肿瘤杂志,2003,25(6):566-568. Li WL,Yu JM,Liu GH,et al. Objective to study the relationship between imaging and pathological target area of non small cell lung cancer[J].Chin J Oncol,2003,25(6):566-568.
2017, Vol. 26 
